Advertisement
Screener

Tilray Brands, Inc. (TLRY) Debt Securities, Unrealized Gain (Loss)

2.8 / 5 stars · 68/120 Roast Me

Tilray Brands, Inc. Debt Securities, Unrealized Gain (Loss)

Tilray Brands, Inc. (TLRY) reported Debt Securities, Unrealized Gain (Loss) of -$71.43 million for the 12-month period ending 2022-05-31, per its 10-K filed 2022-07-28.

Discontinued › Income Statement › Other Income

us-gaap:DebtSecuritiesUnrealizedGainLoss · last filed 2022-07-28

  • Tilray Brands, Inc. debt securities, unrealized gain (loss) for the quarter ending 2022-05-31 was -$70.78M.
  • Tilray Brands, Inc. debt securities, unrealized gain (loss) for the quarter ending 2022-02-28 was -$52.00K.
  • Tilray Brands, Inc. debt securities, unrealized gain (loss) for the quarter ending 2021-11-30 was $52.00K.
  • Tilray Brands, Inc. debt securities, unrealized gain (loss) for the quarter ending 2021-08-31 was -$649.00K.
  • Tilray Brands, Inc. debt securities, unrealized gain (loss) for fiscal 2022 was -$71.43M.
  • Tilray Brands, Inc. debt securities, unrealized gain (loss) for fiscal 2021 was -$3.82M.
  • Tilray Brands, Inc. debt securities, unrealized gain (loss) for fiscal 2020 was -$5.48M.
  • Tilray Brands, Inc. debt securities, unrealized gain (loss) for fiscal 2019 was -$2.57M.
Period endDebt Securities, Unrealized Gain (Loss) 3 monthDebt Securities, Unrealized Gain (Loss) 6 monthDebt Securities, Unrealized Gain (Loss) 9 monthDebt Securities, Unrealized Gain (Loss) 12 month
2022-05-31-$70.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28
-$70.83M
derived: sum of 2 quarters · filed 2022-07-28
-$70.78M
derived: sum of 3 quarters · filed 2022-07-28
-$71.43M
10-K · filed 2022-07-28
2022-02-28-$52.00K
10-Q · filed 2022-04-06
$0.00
derived: sum of 2 quarters · filed 2022-04-06
-$649.00K
10-Q · filed 2022-04-06
-$1.83M
derived: sum of 4 quarters · filed 2022-07-28
2021-11-30$52.00K
10-Q · filed 2022-01-10
-$597.00K
10-Q · filed 2022-01-10
-$1.77M
derived: sum of 3 quarters · filed 2022-07-28
-$4.42M
derived: sum of 4 quarters · filed 2022-07-28
2021-08-31-$649.00K
10-Q · filed 2021-10-07
-$1.83M
derived: sum of 2 quarters · filed 2022-07-28
-$4.47M
derived: sum of 3 quarters · filed 2022-07-28
2021-05-31-$1.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28
-$3.82M
derived: sum of 2 quarters · filed 2022-07-28
-$3.82M
10-K · filed 2022-07-28
2021-02-28-$2.65M
10-Q · filed 2022-04-06
-$2.65M
10-Q · filed 2022-04-06
2020-05-31-$5.48M
10-K · filed 2022-07-28
2019-09-30$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$29.00K
derived: sum of 2 quarters · filed 2019-11-13
$17.00K
10-Q · filed 2019-11-13
2019-06-30$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
$6.00K
10-Q · filed 2019-08-13
2019-05-31-$2.57M
10-K · filed 2021-07-28
2019-03-31-$12.00K
10-Q · filed 2019-05-15
2018-12-31$69.00K
10-Q · filed 2019-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87